Atlantic Coal (LON:ATC) shares advanced 10% on the day as it saw anthracite sales rise strongly in its latest quarter as it started to sell coal straight from its mine at Stockton, Pennsylvania.
Combined sales of run of mine coal (ROM) and clean coal rose 39% to 61,700 tons compared to the previous three months, with ROM production 12% higher at 161,000 tons.
Clean coal produced was little changed at 45,100 tons despite a 16 day outage as the washing plant was upgraded.
It was one of a mixed news bag. Here are some highlights....
Medtech firm ANGLE (LON:AGL) revealed it was well-funded to continue the strong progress made in the financial year just ended, it told investors.
The company, known for its pioneering Parsortix cell separation system, looked back on a busy year in its results statement covering the year to the end of April.
Highlights included the first clinical application for the Parsortix system in ovarian cancer, following a 65-patient study published by the Medical University of Vienna; the addition of six more world-class cancer centres, making a total of nine key opinion leading bodies on board with ANGLE; uniformly positive results published by five key opinion leaders of performance of the Parsortix system; and the initiation of the company's first two corporate collaborations.
In tech news, shares in Cloudbuy (LON:BUY), the developer of a leading e-commerce platform for buyers and sellers, shot up as it reported "pleasing" progress in its first half and a £1mln shot in the arm from a US investor.
The firm's Cloud-based applications are also used for company spend analysis, content management and big data.
The AIM-company said the six months to June 30 had seen "increasing traction" globally on its products - resulting in a strong pipeline of potential deals, which had a value of £51mln as at the end of June.
Aggregates group Breedon (LON:BREE) saw exceptional performances in both England and Scotland as interim sales and profits surged ahead.
Buoyant demand, good weather, acquisitions chipping in and the fall in oil prices all contributed to make it a bumper half, said the quarry owner.
Underlying profits [EBITDA] jumped by 54% to of £27.3mln in the six months to June, which was ahead of expectations, while revenues climbed 28% to £160.5mln. Pre-tax profits rose 92% to £17.5mln.
Elsewhere, Allergy Therapeutics’ (LON:AGY) sales will beat expectations for the year to June with revenues rising 11% on a constant currency basis, it said.
“This double digit growth rate in a flat market demonstrates that Allergy Therapeutics has outperformed the market, gaining market share of approximately one percent a year” the company said.
Revenues on a constant currency basis are expected to be £46.6mln (£42mln last year), with reported revenues of £43.2mln (42mln).
Elsewhere, gas production continues to ramp up sharply at Victoria Oil & Gas's (LON:VOG) fields in Cameroon, it emerged today..
Average gas production of 12.6mln standard cubic feet a day (mmscf/d) during the second quarter of 2015, up from 4.5mln in the preceding quarter and 2.6mln in the same quarter of 2014.
Production reached a peak of 16.9mmscf/d during the quarter, with an average five day working week output of 13.1mmscf/d.
Sticking to the sector, Madagascar Oil (LON:MOIL) got a boost today as US power group Symbion unveiled plans to build seven electricity plants across the island.
The plants will produce 180 Mw of power and use a combination of biomass, solar and heavy fuel oil as the feedstock.
The largest plant will produce 116MW and be located near to the Tsimiroro field currently under development by Madagascar Oil. Symbion said it plans to use heavy fuel oil produced locally.